ScienceDaily: Targeting Pancreatic Cancer: "n the March 1 issue, Drs. Johanna Joyce (MSKCC), Douglas Hanahan (UCSF) and colleagues lend new insight into how broad-spectrum cysteine cathepsin inhibitors combat pancreatic cancer, and provide new data to help refine the design of more precisely targeted anti-cathepsin therapies.

'These results may help guide the design of clinical trials aimed to assess cathepsin inhibitors as cancer therapies' said Dr. Joyce"